Invisible ink: Some markers for copy-neutral loss-of-heterozygosity chimerism are only detectable when they disappear

被引：0
|
作者：
Carter, M. [1 ]
Garcia-Gomez, J. [1 ]
Al Malki, M. [1 ]
Gendzekhadze, K. [1 ]
Nelson, W. [2 ]
Pyo, C. [2 ]
Geraghty, D. [2 ]
机构：
[1] City Hope Natl Med Ctr, Histocompatib, Duarte, CA USA
[2] Scisco Genet, Seattle, WA USA
来源：
HUMAN IMMUNOLOGY | 2023年 / 84卷
关键词：
D O I：
10.1016/j.humimm.2023.08.021
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P119
引用
收藏
页码：77 / 78
页数：2
相关论文
共 7 条
  • [1] Copy-Neutral Loss-of-Heterozygosity Adds Diagnostic and Prognostic Information to the Molecular Profiling of Hematological Malignancies
    Walter, Wencke
    Muller, Heiko
    Haferlach, Claudia
    Baer, Constance
    Hutter, Stephan
    Nadarajah, Niroshan
    Kern, Wolfgang
    Haferlach, Torsten
    Meggendorfer, Manja
    BLOOD, 2021, 138
  • [2] Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response
    Kumar, Yogesh
    Yang, Jianfeng
    Hu, Taobo
    Chen, Lei
    Xu, Zhi
    Xu, Lin
    Hu, Xiao-Xia
    Tang, Gusheng
    Wang, Jian-Min
    Li, Yi
    Poon, Wai-Sang
    Wan, Weiqing
    Zhang, Liwei
    Mat, Wai-Kin
    Pun, Frank W.
    Lee, Peggy
    Cheong, Timothy H. Y.
    Ding, Xiaofan
    Ng, Siu-Kin
    Tsang, Shui-Ying
    Chen, Jin-Fei
    Zhang, Peng
    Li, Shao
    Wang, Hong-Yang
    Xue, Hong
    BMC MEDICAL GENOMICS, 2015, 8
  • [3] Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response
    Yogesh Kumar
    Jianfeng Yang
    Taobo Hu
    Lei Chen
    Zhi Xu
    Lin Xu
    Xiao-Xia Hu
    Gusheng Tang
    Jian-Min Wang
    Yi Li
    Wai-Sang Poon
    Weiqing Wan
    Liwei Zhang
    Wai-Kin Mat
    Frank W. Pun
    Peggy Lee
    Timothy H. Y. Cheong
    Xiaofan Ding
    Siu-Kin Ng
    Shui-Ying Tsang
    Jin-Fei Chen
    Peng Zhang
    Shao Li
    Hong-Yang Wang
    Hong Xue
    BMC Medical Genomics, 8
  • [4] The Null Q0Ourem Variant Within a Copy-Neutral Loss-of-Heterozygosity Event Causing Alpha-1 Antitrypsin Deficiency
    Gaudreault, Nathalie
    Blouin, Claudia
    Haillot, Annie
    Milot, Julie
    Maltais, Francois
    Bosse, Yohan
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2022, 66 (06) : 700 - 702
  • [5] Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders
    Pugh, Trevor J.
    Fink, James M.
    Lu, Xinyan
    Mathew, Susan
    Murata-Collins, Joyce
    Willem, Pascale
    Fang, Min
    CANCER GENETICS, 2018, 228 : 184 - 196
  • [6] Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia
    Chun, Kathy
    Wenger, Gail D.
    Chaubey, Alka
    Dash, D. P.
    Kanagal-Shamanna, Rashmi
    Kantarci, Sibel
    Kolhe, Ravindra
    Van Dyke, Daniel L.
    Wang, Lu
    Wolff, Daynna J.
    Miron, Patricia M.
    CANCER GENETICS, 2018, 228 : 236 - 250
  • [7] Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group
    Xu, Xinjie
    Bryke, Christine
    Sukhanova, Madina
    Huxley, Emma
    Dash, D. P.
    Dixon-Mciver, Amanda
    Fang, Min
    Griepp, Patricia T.
    Hodge, Jennelle C.
    Iqbal, Anwar
    Jeffries, Sally
    Kanagal-Shamanna, Rashmi
    Quintero-Rivera, Fabiola
    Shetty, Shashi
    Slovak, Marilyn L.
    Yenamandra, Ashwini
    Lennon, Patrick A.
    Raca, Gordana
    CANCER GENETICS, 2018, 228 : 218 - 235
1